Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Transforming Cancer Care through Genomic Testing

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Pathophysiology

Targeted Cancer Therapies

Caring for a Loved One with Cancer

The Effects of Cancer on Family Life

Cutaneous Manifestations of Internal Malignancy

Cancer Classification

Insight into Cancer Vaccines

Microfluidic cancer treatment screen combined with flow cytometry

See more featured articles »

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Secondary Brain Cancer

Hypoxia Markers and Their Importance

Cancer Pain

Is Cancer a Metabolic Disorder?

Cancer Prognosis

Cancer Epidemiology

Assay for Monitoring and Treating Malignant Brain Tumors

Using Biomarkers to Detect Cancer

What is the Tumor Microenvironment?

Investigating the Molecular Mechanisms of Cancer

What is Merkel Cell Carcinoma?

CDK9 and Cancer

Cancer Research

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is Immunochemotherapy?

Effects of Social and Economic Deprivation on Cancer Mortality

British Pioneers in Cancer Biology

What is Cancer?

Pediatric Cancer

Cancer Pain Management

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Overview of Cell Viability and Cytotoxicity

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What Role do Biobanks Play in Cancer Research?

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Management

Cancer Prevention: Lowering your Risk

Insights into Oncofertility

What is Cancer of Unknown Primary?

The Biochemistry of Breast Cancer Screening

Why are Cancer Cell Lines Useful?

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Tumorigenesis?

What Causes Cancer?

Cancer Diagnosis

Hot vs Cold: the differences between tumor types

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Myc Mutations and Cancer

Secondary Lung Cancer

Cancer History

Metastatic Migration in Cancer may be Influenced by Metabolism

Living with Cancer Pain

Cancer Symptoms

Exploiting Enzymes in Cancer Diagnosis and Therapy

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Acidosis and Tumor Progression

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Glossary

Latest Cancer News and Research

Blood markers reveal metabolic impact of ultra-processed food consumption

Consumption of ultra-processed food (UPF) results in a distinct metabolic 'signature' in the blood, associated with potentially adverse health conditions, a new study by an international team of researchers finds.

6 Jul 2026

New R package advances multi-pathway cell death analysis

Announcing a new article publication in BIO Integration. The authors of this article developed CellDeathAnalysis (v0.4.0), an R package providing a unified framework for analyzing 14 cell death pathways in bulk RNA-seq data.

6 Jul 2026

FDA approves new therapy for double-positive metastatic breast cancer

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led by Otto Metzger, MD, Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute.

6 Jul 2026

New viral insights lay foundation for treating infection with JC polyomaviruses

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

6 Jul 2026

Case study shows how accurate diagnosis can guide personalized treatment for renal oncocytoma

A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled "Renal oncocytoma: Α case report and literature review."

6 Jul 2026

Psychiatry may be moving closer to precision medicine

For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant after another in hopes that one will eventually help.

6 Jul 2026

Study tracks why rural residents face higher chronic disease risks

Following the release of data from Assumption Parish earlier this year, researchers at LSU's Pennington Biomedical Research Center have published the first set of data from the Risks Underlying Rural Areas Longitudinal, or RURAL, Heart and Lung study in Franklin Parish. The data book for Franklin Parish is now available to explore.

6 Jul 2026

Men face higher risk of late-stage cancer diagnoses than women

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).

6 Jul 2026

Engineered immune cells suppress asthma symptoms in allergic mice

Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response against leukemias and other cancers.

6 Jul 2026

New method helps scientists better understand DNA organization

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows scientists to better understand how DNA is organized and regulated inside our cells.

6 Jul 2026

Lifelong violence against women linked to significantly earlier menopause

The research, published in the journal Maturitas, links trauma experienced to the onset of the menopause up to 20 months earlier and an increase in hot flushes, depression and cardiometabolic health problems.

6 Jul 2026

Persistent disparities found in preventive cancer care for sexual and gender minority populations

New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender identity (SOGI) populations.

6 Jul 2026

New study highlights noninvasive biomarkers for colorectal cancer detection

Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional methods that often require surgical interventions or tissue biopsies.

6 Jul 2026

Allergies show a small but significant link to later cancer risk

A systematic review and meta-analysis of 28 cohort-based studies found a weak but statistically significant association between allergic diseases and later cancer incidence. The signal was strongest in the Western Pacific region and among people with asthma, but high heterogeneity and limited subgroup evidence mean the findings require caution.

5 Jul 2026

Engineered scaffold restores skull growth in craniosynostosis mouse models

An engineered triphasic biomaterial scaffold successfully recreated the cranial suture stem cell niche lost in craniosynostosis, a condition that causes premature fusion of skull bones.

5 Jul 2026

Targeted therapy shows promise against KRAS-driven metastatic pancreatic cancer

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026